Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...
Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.
The teenager needs access to treatment that's only available in Europe and comes at a cost of £300,000. | ITV News Granada ...
I’ve lost a lot of my fine motor skills, my eyesight is getting fuzzier, and my speech is slurring a lot more. I would give ...
Prominently featured in The Inner Circle, Rebecca K. Ledwin, PNP-BC is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for her contributions to Pediatric Nursing and ...
IntraBio’s Aqneursa receives European Commission’s marketing approval for treatment of Niemann-Pick Type C disease: Austin, Texas Saturday, January 24, 2026, 14:00 Hrs [IST] I ...
Microsoft Corp. on Wednesday announced that fiscal year 2026 second-quarter financial results are available on its Investor Relations website. The direct link to the earnings press release ...
ClearPoint Neuro is positioned for robust growth in 2026, driven by IRRAS, the PRISM 1.5T system clearance, and the company's new CRO facility. While the immediate future of uniQure's AMT-130 remains ...
In connection with Dr. Bhalla’s appointment, Eric Adler , MD, currently Head of Research at Lexeo Therapeutics, will serve as President and Chief Executive Officer of cardiac precision medicines ...
A new study published in the Journal of American Medical Association showed that adding levodopa to normal inpatient ...
A woman who is alleged to have failed in providing vet care, food and shelter to 27 horses, including ponies and a pregnant ...
There was an almost four-fold increase in the number of people being treated for the addictive use of volatile inhalants such as aerosols and nitrous oxide in a three-year period, an Oireachtas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results